Serial #79230585
LIVE

Serial Number

79230585

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 8, 2018

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79230585 Trademark

Serial Number: 79230585 • Registration: 5563317

Serial #79230585 is a trademark filed by NOVARTIS AG on February 8, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 8, 2018

Registration Date

September 18, 2018

Published for Opposition

July 3, 2018

Cancellation Date

February 26, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sep 20, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Sep 20, 2024 DETH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 18, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 17, 2019 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jan 3, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 3, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 18, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 18, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 3, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 3, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 13, 2018 NONP
REFUSAL PROCESSED BY IB
Jun 1, 2018 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 25, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 22, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 22, 2018 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 17, 2018 RFCS
REFUSAL PROCESSED BY MPU
May 17, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 12, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 11, 2018 CNRT
ASSIGNED TO EXAMINER
May 10, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 28, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 23, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 19, 2018 SDRC